Clinical applications of the diagnosis of p53 alterations in squamous cell carcinoma of the head and neck.
Alteration of the p53 tumor suppressor gene implies an extremely high risk of developing malignancy, and mutation of the gene is one of the most frequent genetic changes found in human cancer. Squamous cell carcinoma of the head and neck (SCCHN) shows a high incidence of p53 tumor suppressor gene alterations; the latter therefore appears to play an important role in the pathogenesis and progression of such neoplasms. The loss of p53 protein activity may be due to many p53 gene mutations or to the action of certain viruses that infect the oral cavity. Local recurrence is the most common cause of mortality after SCCHN surgery; in this sense, p53 gene mutations have been observed in tissue adjacent to the tumor, and constitute a good prognostic marker of tumor recurrence. The analysis of p53 tumor suppressor gene alterations in SCCHN affords important information on the diagnosis, prognosis and treatment of affected patients - such alterations representing an indicator in high risk patients of the convenience of applying more aggressive adjuvant therapies.
Lopez-Martinez
M
M
Departamento de Z y Dinamica celular Facultad de Farmacia Universidad de Pais Vasco Paseo de la Universidad 7 01006 Vitoria, GASTEIZ. gcpmagom@lg.ehu.es
Anzola
M
M
Cuevas
N
N
Aguirre
J M
JM
De-Pancorbo
M
M
D002294:Carcinoma, Squamous Cell / Q000175:diagnosis* / Q000235:genetics* / Q000628:therapy; D002869:Chromosome Aberrations; D004252:DNA Mutational Analysis; D016158:Genes, p53 / Q000235:genetics*; D006258:Head and Neck Neoplasms / Q000175:diagnosis* / Q000235:genetics* / Q000628:therapy; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis / Q000235:genetics; D027383:Papillomaviridae / Q000235:genetics; D011379:Prognosis